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ANTHONY G. ROBSON, DOROTHY A. THOMPSON, ANTHONY T. MOORE, AND MICHEL MICHAELIDES PURPOSE: To describe a series of patients with molecu-
larly confirmed mutation in BEST1 causing Best disease
but with unilateral clinical manifestation.
 DESIGN: Retrospective observational case series.
 METHODS: SETTING: Moorfields Eye Hospital and Great
Ormond Street Hospital, London (United Kingdom).
PATIENTS: Five patients (10 eyes) with uniocular manifes-
tation ofBEST1mutation causing Best disease were ascer-
tained retrospectively from the clinical and genetic
databases. MAIN OUTCOME MEASURES: Patients had full
ophthalmologic examination, color fundus photography,
fundus autofluorescence imaging, spectral-domain optical
coherence tomography, and detailed electrophysiological
assessment. Genetic testing was performed.
 RESULTS: All cases had a clinical appearance typical of
and consistent with Best disease at various stages, except
that the presentation was unilateral. The reduced electro-
oculogram light rise was bilateral and in the context of
normal electroretinograms therefore indicates generalized
dysfunction at the level of the retinal pigment epithelium.
 CONCLUSIONS: Mutation in BEST1 has variable
penetrance and expressivity, and can be uniocular.
The clinical and electrophysiological features described
assist targeted mutational screening and alert to the
potential diagnosis even when there is an atypical unilat-
eral presentation. (Am J Ophthalmol 2016;169:
24–32.  2016 The Authors. Published by Elsevier
Inc. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
B
EST DISEASE WAS FIRST DESCRIBED BY ADAMS IN
1883, but was named after Dr Friedrich Best, who
identified an autosomal dominant mode of inheri-
tance after examining 7 members of a pedigree segregating
this disorder.1 Best disease (vitelliform macular dystrophy)
is an early-onset macular dystrophy typically characterized
by bilateral accumulation of subretinal deposit resultingr publication May 31, 2016.
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 2016 THE AUTHORS. PUBfrom heterozygous mutations in the BEST1 gene (OMIM
153700). It is a slowly progressive macular dystrophy with
usual onset in childhood but sometimes in later teenage
years. The classic appearance of yolk-like lesions is a strik-
ing feature and distinguishes it from other hereditary
conditions. The phenotype can vary significantly, even
within the same family. The most extreme example of
this is nonpenetrance of the macular changes in the pres-
ence of electrophysiological evidence of disease.
The retinal changes are typically bilateral and relatively
symmetrical, but rarely, inherited BEST1 mutations may
be associated with unilateral maculopathy, with only 3
cases reported in the literature to date.1,2 The present
report describes a series of 5 molecularly proven cases
with unilateral presentation of Best disease.METHODS
PATIENTSWEREASCERTAINEDRETROSPECTIVELY FROMTHE
clinical and genetic databases of Moorfields Eye Hospital,
London, United Kingdom and Great Ormond Street Hos-
pital, London, United Kingdom. Patients and family mem-
bers received full ophthalmologic examination including
visual acuity testing using Snellen charts, color fundus
photography, fundus autofluorescence imaging, and
spectral-domain optical coherence tomography (Heidel-
berg Engineering, Heidelberg, Germany). Electrophysio-
logical assessment included full-field and pattern
electroretinography and electrooculography.3–5 Blood
samples were taken for DNA extraction and mutation
screening of BEST1 by Sanger sequencing. The study was
approved by the local ethics committee of Moorfields Eye
Hospital. All patients, or their parents, gave informed
consent and the study conformed to the tenets of the
Declaration of Helsinki and complied with the Health
Insurance Portability and Accountability Act.RESULTS
 FAMILY 1 (CASES 1 AND 2): A 12-year-old boy (Case 1,
Table) presented to the eye clinic with recent onset of
blurred distance vision in the left eye. Best-corrected
logMAR visual acuity was 0.02 in the right eye and 0.06
in the left. Near vision was N5 in each eye and no distor-
tion was reported using an Amsler grid. There was a family0002-9394
http://dx.doi.org/10.1016/j.ajo.2016.05.024
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VOL. 169 UNILATERAL BEST1-ASSOChistory of macular dystrophy affecting his grandmother,
who was registered blind, and his maternal uncle, who
maintained driving vision. Funduscopy of the left eye
showed a yolk-like elevated lesion at the central macula
that was hyperautofluorescent on fundus autofluorescence
imaging (Figure 1). Spectral-domain optical coherence
tomography revealed subretinal fluid in addition to the
subretinal deposit. Fundus examination, fundus autofluor-
escence, and spectral-domain optical coherence tomogra-
phy of the right eye were normal. His mother (Case 2,
Table) had similar uniocular features on funduscopy at
the posterior pole of the right eye but was asymptomatic.
Fundus autofluorescence showed bilateral, relatively sym-
metrical areas of increased autofluorescence in the nasal
retina, but spectral-domain optical coherence tomogra-
phy abnormality was present only at the right macula
(Figure 2). Electrophysiological testing showed absence
of the electrooculogram light rise in both eyes of both
mother and son. Full-field electroretinography was normal
in both patients. Pattern electroretinograms were within
normal limits in both eyes of the son, showing minimal
interocular difference with lower amplitudes in the left
eye using a 15-degree field stimulus. Pattern electroreti-
nography was not performed in Case 2 (mother).
In both patients, genetic testing identified a previously
reported heterozygous sequence variant, c.692G>C,
p.Ser231Thr, in BEST1.6
 CASE 3: A 16-year-old male subject presented with
reduced vision in his right eye (Table). His father had
been diagnosed with Best disease at an early age based on
the presence of bilateral vitelliform lesions, but remained
asymptomatic until the age of 30. Two paternal aunts
were known to have Best disease. Best-corrected logMAR
visual acuity was -0.1 in the right eye and 0.0 in the left.
Funduscopy, fundus autofluorescence, and spectral-
domain optical coherence tomography of the right eye
revealed macular atrophy, yellow subretinal and subretinal
pigment epithelium deposition, and subretinal fluid
(Figure 3). The left eye was normal on funduscopy and im-
aging. The pattern electroretinogram was significantly
reduced in the right eye but normal in the left eye. Full-
field electroretinograms were normal in both eyes. Electro-
oculogram light rise was subnormal in both eyes. BEST1
screening identified that both father and son were heterozy-
gous for a previously reported sequence variant, c.47C>T,
p.Ser16Phe, in exon 2 of BEST1.7
 CASE4: A 17-year-old asymptomatic female patient was
found by her optometrist to have an abnormal appearance
of the right macula (Table). There was no known family
history of eye disease. Best-corrected logMAR visual acu-
ity was 0.06 in the right eye and 0.0 in the left. Fundus
examination showed unilateral vitelliform changes in
the right eye associated with increased autofluorescence
on fundus autofluorescence and subretinal and subretinal25IATED RETINOPATHY
FIGURE 1. Multimodal imaging of (Left column) the right eye and (Right column) the left eye of patient (Case 1) with unilateral
BEST1-associated retinopathy. Color fundus photographs (Top row), infrared reflectance images (Second row), horizontal B-scans
derived from spectral-domain optical coherence tomography through the foveal region (Third row), and fundus autofluorescence
images (Bottom row) of both eyes are shown. The left eye presents with a typical yolk-like elevated lesion at the central macula
that was hyperautofluorescent on fundus autofluorescence; spectral-domain optical coherence tomography revealed subretinal fluid
in addition to the subretinal deposit.
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FIGURE 2. Multimodal imaging of (Left column) the right eye and (Right column) the left eye of patient (Case 2; mother of patient
in Case 1) with unilateral BEST1-associated retinopathy. Color fundus photography (Top row), infrared reflectance imaging (Second
row), horizontal B-scan through the foveal region by spectral-domain optical coherence tomography (Third row), and fundus auto-
fluorescence (Bottom row) are presented. Subretinal deposit as detected by spectral-domain optical coherence tomography was
present only in the right macula. Fundus autofluorescence showed bilateral, relatively symmetrical areas of increased autofluores-
cence in the nasal retina.
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FIGURE 3. Multimodal imaging of (Left column) the right eye and (Right column) the left eye of patient (Case 3) with unilateral
BEST1-associated retinopathy. Infrared reflectance imaging (Top row), horizontal B-scan through the foveal region by spectral-
domain optical coherence tomography (Middle row), and fundus autofluorescence (Bottom row) are shown. The right eye shows
macular atrophy, yellow subretinal and subretinal pigment epithelium deposition, and subretinal fluid.pigment epithelium deposition on spectral-domain optical
coherence tomography (Figure 4). The left eye was normal
on funduscopy and multimodal imaging. Her father was
asymptomatic and funduscopy was normal. However,
fundus autofluorescence imaging revealed hyperautofluor-
escent subretinal deposits in both eyes. Both father and
daughter had significantly reduced electrooculogram light
rise in both eyes, consistent with Best disease. In both28 AMERICAN JOURNAL OFthe father and the daughter, BEST1 screening identified
a previously reported heterozygous disease-causing muta-
tion c.874G>A, p.Glu292Lys, in exon 8 of BEST1.8
 CASE 5: A 27-year-old male patient was reviewed with
longstanding poor vision in the right eye (Table).
Best-corrected logMAR visual acuity was hand movements
in the right eye and 0.0 in the left. Fundus examinationSEPTEMBER 2016OPHTHALMOLOGY
FIGURE 4. Multimodal imaging of (Left column) the right eye and (Right column) the left eye of patient (Case 4) with unilateral
BEST1-associated retinopathy. Color fundus photographs (Top row), infrared reflectance images (Second row), horizontal
B-scans derived from spectral-domain optical coherence tomography through the foveal region (Third row), and fundus autofluores-
cence images (Bottom row) of both eyes are presented. The right eye shows vitelliform changes associated with increased autofluor-
escence on fundus autofluorescence and subretinal and subretinal pigment epithelium deposition on spectral-domain optical
coherence tomography.
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showed a macular scar in the right eye, but was normal on
the left. Fundus autofluorescence imaging showed a large
area of macular hypofluorescence and corresponding area
of subretinal fibrosis on spectral-domain optical coherence
tomography (Figure 5). Full-field electroretinograms were
normal bilaterally. Unfortunately, electrooculography was
technically unsatisfactory on 2 occasions. His mother and
sister were reported to be affected but family members
were not available for examination. Genetic testing
revealed a heterozygous previously reported variant in
BEST1, c.892T>G, p.Phe298Val. Other mutations of
codon 298 have previously been reported.9,10DISCUSSION
THIS REPORT DESCRIBES 5 PATIENTS WITH UNIOCULAR
clinical manifestation of disease-causing variants in
BEST1 (Best disease). The clinical features were otherwise
typical of the disorder. Three patients presented between
12 and 17 years of age with good visual function. In 2 cases
a parent was identified as being affected despite being
asymptomatic, and in the final case the father was already
known to have bilateral Best disease.
All cases had appearance typical and consistent with
Best disease except that the presentation was unilateral.
The fundus autofluorescence and spectral-domain optical
coherence tomography imaging demonstrated features of
different stages of Best disease. The reduced electrooculo-
gram light rise was bilateral and, in the context of normal
electroretinograms, therefore indicates generalized
dysfunction at the level of the retinal pigment epithelium.
An abnormal electrooculogram light rise has been previ-
ously reported in BEST1 carriers with normal fundus
appearance and can precede the clinical manifestation of
vitelliform lesions.11,12 While full-field electroretinograms
were within normal limits in all patients, pattern electrore-
tinograms were variable in patients in whom testing was
undertaken: normal in Case 1 (although slight interocular
asymmetry to a 15-degree field) and reduced in the
‘‘affected’’ eye of the patient in Case 3 compared to normal
in the fellow eye.
It is known that Best disease can have reduced pene-
trance and variable expression, but the mechanisms are
poorly understood.1,9,13–19 Variable expressivity is
common in Best disease even within families that carry
the same causative mutation; this is likely to be because
of the influence of modifier genes. Most individuals
diagnosed with Best disease have an affected parent;
however, in autosomal recessive bestrophinopathy, where
patients harbor biallelic variants in BEST1, that is not
the case.20 The proportion of dominant cases caused by
de novo mutations is unknown.
BEST1 encodes the transmembrane protein bestrophin
1, which is located on the basolateral aspect of the plasma30 AMERICAN JOURNAL OFmembrane of retinal pigment epithelium cells. There are
over 200 mutations described in BEST1 (http://www.
retina-international.org/sci-news/databases/mutation-
database/best1-mutation/, last accessed March 5, 2016).
Although the encoded protein’s exact function remains
incompletely described, it has been linked to abnormal
chloride conductance, which likely disrupts fluid transport
across the retinal pigment epithelium and leads to accu-
mulation of debris between Bruch’s membrane and the
retinal pigment epithelium/photoreceptor complex.21–23
However, the colocalization of bestrophin 1 and STIM1
has been reported, and an association with the
endoplasmic reticulum and cytosolic compartment next
to the basolateral membrane, which suggests bestrophin
is also involved in modulation of intracellular Ca2þ
storage, in addition to acting as a Ca2þ-activated Cl
channel, and provides an explanation of why some pa-
tients with Best disease have a normal light rise.24,25
Singh and associates have shown that rhodopsin degra-
dation after photoreceptor outer segment feeding was
delayed in induced pluripotent stem cell–derived retinal
pigment epithelium cells from patients with Best disease
compared with induced pluripotent stem cell–derived
retinal pigment epithelium cells from unaffected siblings,
directly implicating impaired photoreceptor outer segment
handling in the pathophysiology of the disease.26 In addi-
tion, stimulated calcium responses differed between Best
disease and normal sibling induced pluripotent stem cell–
derived retinal pigment epithelium, as did oxidative stress
levels after chronic photoreceptor outer segment feeding.26
Best disease is almost always bilateral.2 However, 2
patients have been reported by Querques and associates
with unilateral Best disease and heterozygous mutations
in exon 2 of BEST1, unrelated either to their age or to their
genotype.2 One of these patients, aged 27, shared the
p.T4A mutation with his 23-year-old sibling, who had
bilateral disease (CT08). Similarly, the second patient, a
70-year-old man, had 2 affected family members (aged 10
and 36 years) with bilateral disease that carried the same
p.R25W mutation. Wabbels and associates reported a
7-year-old boy with unilateral disease associated with the
p.Ile295del mutation, which is normally associated with
bilateral disease.1
This series of 5 patients supports that BEST1 mutation
causing Best disease can have a uniocular clinical manifes-
tation, with otherwise typical clinical and imaging features.
The most consistent phenotypic feature, even in Best
disease cases with stage 1 disease and a normal macular
appearance, is a reduced light rise of the electrooculogram.
Electrooculography was bilaterally abnormal in the present
series, indicating generalized retinal pigment epithelium
dysfunction in each eye but with abnormal macular
structure only in 1 eye, stressing the diagnostic importance
of electrooculography. The cause of this unilateral presen-
tation, rare in other inherited retinal dystrophies, is
currently unknown.SEPTEMBER 2016OPHTHALMOLOGY
FIGURE 5. Multimodal imaging of (Left column) the right eye and (Right column) the left eye of patient (Case 5) with unilateral
BEST1-associated retinopathy. Color fundus photographs (Top row), infrared reflectance images (Second row), horizontal B-scans
derived from spectral-domain optical coherence tomography through the foveal region (Third row), and fundus autofluorescence im-
ages (Bottom row) of both eyes are presented. In color fundus photography, there is a macular scar in the right eye that corresponds to
a large area of macular hypoautofluorescence on fundus autofluorescence imaging and subretinal fibrosis on spectral-domain optical
coherence tomography.
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